180 related articles for article (PubMed ID: 23958950)
1. Long-term health-related quality of life evaluated more than 20 years after hematopoietic stem cell transplantation for thalassemia.
La Nasa G; Caocci G; Efficace F; Dessì C; Vacca A; Piras E; Sanna M; Marcias M; Littera R; Carcassi C; Lucarelli G
Blood; 2013 Sep; 122(13):2262-70. PubMed ID: 23958950
[TBL] [Abstract][Full Text] [Related]
2. Long-term Effect of Hematopoietic Stem Cell Transplantation on the Quality of Life of Patients with β-thalassemia Major in Guangxi, China - A Cross-sectional Study.
Zhai L; Liu Y; Huo R; Pan Z; Zhang Y; Li Z; Li F; Fan J; Wei W
Curr Stem Cell Res Ther; 2023; 18(3):410-416. PubMed ID: 35538806
[TBL] [Abstract][Full Text] [Related]
3. Prospective assessment of health-related quality of life in pediatric patients with beta-thalassemia following hematopoietic stem cell transplantation.
Caocci G; Efficace F; Ciotti F; Roncarolo MG; Vacca A; Piras E; Littera R; Dawood Markous RS; Collins GS; Ciceri F; Mandelli F; Marktel S; La Nasa G
Biol Blood Marrow Transplant; 2011 Jun; 17(6):861-6. PubMed ID: 20870029
[TBL] [Abstract][Full Text] [Related]
4. [Impact of the type of hematopoietic stem-cell transplant on quality of life and psychopathology].
Janicsák H; Masszi T; Reményi P; Ungvari GS; Gazdag G
Ideggyogy Sz; 2023 Jan; 76(1-2):25-35. PubMed ID: 36892298
[TBL] [Abstract][Full Text] [Related]
5. Quality of life assessment in hematopoietic stem cell transplantation performed on thalassemia major patients.
Uygun V; Tayfun F; Akcan M; Karasu GT; Kupesiz A; Hazar V; Yeşilipek A
Pediatr Hematol Oncol; 2012 Aug; 29(5):461-71. PubMed ID: 22712884
[TBL] [Abstract][Full Text] [Related]
6. Long-term survival of beta thalassemia major patients treated with hematopoietic stem cell transplantation compared with survival with conventional treatment.
Caocci G; Orofino MG; Vacca A; Piroddi A; Piras E; Addari MC; Caria R; Pilia MP; Origa R; Moi P; La Nasa G
Am J Hematol; 2017 Dec; 92(12):1303-1310. PubMed ID: 28850704
[TBL] [Abstract][Full Text] [Related]
7. Transplant Outcomes in Beta-Thalassemia Major Patients Receiving Combined Granulocyte Colony-Stimulating Factor-Primed Bone Marrow and Cord Blood Graft Compared to Granulocyte Colony-Stimulating Factor-Primed Bone Marrow Alone.
Wen J; Haque Q; Pei F; Chen L; Ruan Y; Liu X; He Y; Feng X; Li C; Wu X
Acta Haematol; 2018; 140(1):20-29. PubMed ID: 30071526
[TBL] [Abstract][Full Text] [Related]
8. Unrelated bone marrow transplantation for beta-thalassemia patients: The experience of the Italian Bone Marrow Transplant Group.
La Nasa G; Argiolu F; Giardini C; Pession A; Fagioli F; Caocci G; Vacca A; De Stefano P; Piras E; Ledda A; Piroddi A; Littera R; Nesci S; Locatelli F
Ann N Y Acad Sci; 2005; 1054():186-95. PubMed ID: 16339665
[TBL] [Abstract][Full Text] [Related]
9. Thalassemia patients in transfussion dependent period and after hematopoietic stem cell transplantation: how are the psychiatric status and life quality of these patients?
Cikili-Uytun M; Eroglu M; Ertem M; İleri DT; Ince E; Günay Kilic B
Pediatr Hematol Oncol; 2023; 40(7):617-628. PubMed ID: 37519029
[TBL] [Abstract][Full Text] [Related]
10. Hematopoietic stem cell transplantation for children with β-thalassemia major: multicenter experience in China.
Li XY; Sun X; Chen J; Qin MQ; Luan Z; Zhu YP; Fang JP
World J Pediatr; 2018 Feb; 14(1):92-99. PubMed ID: 29511925
[TBL] [Abstract][Full Text] [Related]
11. Comparison between an artificial neural network and logistic regression in predicting acute graft-vs-host disease after unrelated donor hematopoietic stem cell transplantation in thalassemia patients.
Caocci G; Baccoli R; Vacca A; Mastronuzzi A; Bertaina A; Piras E; Littera R; Locatelli F; Carcassi C; La Nasa G
Exp Hematol; 2010 May; 38(5):426-33. PubMed ID: 20206661
[TBL] [Abstract][Full Text] [Related]
12. Quality of Life after Allogeneic Hematopoietic Cell Transplantation According to Affected Organ and Severity of Chronic Graft-versus-Host Disease.
Kurosawa S; Oshima K; Yamaguchi T; Yanagisawa A; Fukuda T; Kanamori H; Mori T; Takahashi S; Kondo T; Kohno A; Miyamura K; Umemoto Y; Teshima T; Taniguchi S; Yamashita T; Inamoto Y; Kanda Y; Okamoto S; Atsuta Y
Biol Blood Marrow Transplant; 2017 Oct; 23(10):1749-1758. PubMed ID: 28669922
[TBL] [Abstract][Full Text] [Related]
13. Co-transplantation of bone marrow-derived mesenchymal stem cells with hematopoietic stem cells does not improve transplantation outcome in class III beta-thalassemia major: A prospective cohort study with long-term follow-up.
Rostami T; Maleki N; Kasaeian A; Nikbakht M; Kiumarsi A; Asadollah Mousavi S; Ghavamzadeh A
Pediatr Transplant; 2021 May; 25(3):e13905. PubMed ID: 33179398
[TBL] [Abstract][Full Text] [Related]
14. The quality of life following allogeneic hematopoietic stem cell transplantation - a multicenter retrospective study.
Valkova V; Jircikova J; Trnkova M; Steinerova K; Keslova P; Lanska M; Koristek Z; Raida L; Krejci M; Kruntoradova K; Dolezal T; Benesova K; Cetkovsky P; Trneny M
Neoplasma; 2016; 63(5):743-51. PubMed ID: 27468878
[TBL] [Abstract][Full Text] [Related]
15. Resolved versus Active Chronic Graft-versus-Host Disease: Impact on Post-Transplantation Quality of Life.
Kurosawa S; Yamaguchi T; Oshima K; Yanagisawa A; Fukuda T; Kanamori H; Mori T; Takahashi S; Kondo T; Kohno A; Miyamura K; Umemoto Y; Teshima T; Taniguchi S; Yamashita T; Inamoto Y; Kanda Y; Okamoto S; Atsuta Y
Biol Blood Marrow Transplant; 2019 Sep; 25(9):1851-1858. PubMed ID: 31129353
[TBL] [Abstract][Full Text] [Related]
16. Allogeneic Stem Cell Transplantation in Congenital Hemoglobinopathies Using a Tailored Busulfan-Based Conditioning Regimen: Single-Center Experience.
Zaidman I; Rowe JM; Khalil A; Ben-Arush M; Elhasid R
Biol Blood Marrow Transplant; 2016 Jun; 22(6):1043-1048. PubMed ID: 27016193
[TBL] [Abstract][Full Text] [Related]
17. [Allogeneic hematopoietic stem cell transplantation for beta-thalassemia major].
Li CF; He YL; Zhang YM; Yang M; Wu XD; Bai J
Zhonghua Xue Ye Xue Za Zhi; 2003 Apr; 24(4):174-6. PubMed ID: 12864945
[TBL] [Abstract][Full Text] [Related]
18. HLA-matched family hematopoetic stem cell transplantation in children with beta thalassemia major: the experience of the Turkish Pediatric Bone Marrow Transplantation Group.
Yesilipek MA; Ertem M; Cetin M; Öniz H; Kansoy S; Tanyeli A; Anak S; Kurekci E; Hazar V
Pediatr Transplant; 2012 Dec; 16(8):846-51. PubMed ID: 22931438
[TBL] [Abstract][Full Text] [Related]
19. A Review of Demographic, Medical, and Treatment Variables Associated with Health-Related Quality of Life (HRQOL) in Survivors of Hematopoietic Stem Cell (HSCT) and Bone Marrow Transplantation (BMT) during Childhood.
Reinfjell T; Tremolada M; Zeltzer LK
Front Psychol; 2017; 8():253. PubMed ID: 28344563
[TBL] [Abstract][Full Text] [Related]
20. Quality of life 5 or more years post-autologous hematopoietic stem cell transplant.
Byar KL; Eilers JE; Nuss SL
Cancer Nurs; 2005; 28(2):148-57. PubMed ID: 15815185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]